Ticker
VNDACompany Name
VANDA PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Inventory | Inventory to Assets Ratio |
---|---|---|---|
6/30/2025 | $ 624.75M | $ 11.79M | 1.89% |
3/31/2025 | $ 631.94M | $ 11.98M | 1.9% |
12/31/2024 | $ 656.2M | $ 10.83M | 1.65% |
9/30/2024 | $ 645.12M | $ 10.94M | 1.7% |
6/30/2024 | $ 651.37M | $ 10.82M | 1.66% |
3/31/2024 | $ 652.68M | $ 11.02M | 1.69% |
12/31/2023 | $ 648.44M | $ 11.34M | 1.75% |
9/30/2023 | $ 641.61M | $ 11.28M | 1.76% |
6/30/2023 | $ 641.68M | $ 11.03M | 1.72% |
3/31/2023 | $ 644.53M | $ 11.57M | 1.79% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Inventory / Assets
(=) Inv. to Assets
Inv. to Assets for VANDA PHARMACEUTICALS INC is calculated as follows: Inventory [ $ 7.68M ] / Assets [ $ 515.9M ]
(=) Inv. to Assets [ 1.49% ]
Minimum
Mar 31, 2021
Maximum
Dec 31, 2022
Average
Median
filtered constituents | 4.46K |
---|---|
min | 0% |
max | 98.39% |
average | 6.08% |
median | 0% |
std | 11.11% |